OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides
Cindy L. Berman, Madeleine Antonsson, Sándor Bátkai, Sieto Bosgra, Girish R. Chopda, Wouter H. P. Driessen, Jeffrey W.-D. Foy, Chopie Hassan, Xiao Hu, Hyun Gyung Jang, Meena Meena, Mark Sanseverino, Thomas Thum, Yanfeng Wang, Martin Wild, Jing‐Tao Wu
Abstract
This white paper summarizes the recommendations of the absorption, distribution, metabolism, and excretion (ADME) Subcommittee of the Oligonucleotide Safety Working Group for the characterization of absorption, distribution, metabolism, and excretion of oligonucleotide (ON) therapeutics in nonclinical studies. In general, the recommended approach is similar to that for small molecule drugs. However, some differences in timing and/or scope may be warranted due to the greater consistency of results across ON classes as compared with the diversity among small molecule classes. For some types of studies, a platform-based approach may be appropriate; once sufficient data are available for the platform, presentation of these data should be sufficient to support development of additional ONs of the same platform. These recommendations can serve as a starting point for nonclinical study design and foundation for discussions with regulatory agencies.